BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16899518)

  • 1. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
    Kramer A; van den Hoven M; Rops A; Wijnhoven T; van den Heuvel L; Lensen J; van Kuppevelt T; van Goor H; van der Vlag J; Navis G; Berden JH
    J Am Soc Nephrol; 2006 Sep; 17(9):2513-20. PubMed ID: 16899518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
    van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase in glomerular diseases.
    van den Hoven MJ; Rops AL; Vlodavsky I; Levidiotis V; Berden JH; van der Vlag J
    Kidney Int; 2007 Sep; 72(5):543-8. PubMed ID: 17519955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.
    Raats CJ; Van Den Born J; Berden JH
    Kidney Int; 2000 Feb; 57(2):385-400. PubMed ID: 10652015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
    van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
    Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
    Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
    J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
    Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
    Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
    An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
    Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary heparanase activity in patients with Type 1 and Type 2 diabetes.
    Rops AL; van den Hoven MJ; Veldman BA; Salemink S; Vervoort G; Elving LD; Aten J; Wetzels JF; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2012 Jul; 27(7):2853-61. PubMed ID: 22187315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
    Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
    J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
    Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
    Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy.
    Wapstra FH; Navis GJ; van Goor H; van den Born J; Berden JH; de Jong PE; de Zeeuw D
    Exp Nephrol; 2001; 9(1):21-7. PubMed ID: 11053977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of heparanase in overt diabetic nephropathy.
    van den Hoven MJ; Rops AL; Bakker MA; Aten J; Rutjes N; Roestenberg P; Goldschmeding R; Zcharia E; Vlodavsky I; van der Vlag J; Berden JH
    Kidney Int; 2006 Dec; 70(12):2100-8. PubMed ID: 17051139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
    J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
    Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
    Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
    Bos H; Henning RH; De Boer E; Tiebosch AT; De Jong PE; De Zeeuw D; Navis G
    Kidney Int; 2002 Feb; 61(2):473-80. PubMed ID: 11849387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene expression of heparanase in peripheral blood leukocytes from rats with nephrotic syndrome and its relationship to proteinuria].
    Yan Y; Wang Z; Luo W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):489-91. PubMed ID: 15291107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome.
    Raats CJ; Bakker MA; van den Born J; Berden JH
    J Biol Chem; 1997 Oct; 272(42):26734-41. PubMed ID: 9334259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
    Wijnhoven TJ; Geelen JM; Bakker M; Lensen JF; Rops AL; Kramer AB; Navis G; van den Hoven MJ; van der Vlag J; Berden JH; Wetzels JF; van den Heuvel LP; Monnens LA; van Kuppevelt TH
    Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.